Molecular Features of a Primary Transmural Tracheal Schwannoma: Clinical Experience and Review of the Literature

Cancer Manag Res. 2022 Mar 12:14:1125-1129. doi: 10.2147/CMAR.S353146. eCollection 2022.

Abstract

Primary tracheal schwannoma is a rare disease with no specific symptoms. At the molecular level, neurofibromatosis type 2 (NF2) gene mutation of Schwann cells is the major tumorigenic element. Herein, we present the case of a 54-year-old man with refractory shortness of breath and dry cough, which was resistant to bronchodilator treatment. Computed tomography revealed a transmural mass in the dorsolateral trachea. The tumor was surgically resected, and the diagnosis of schwannoma was confirmed by pathological examination. Furthermore, for this case, we performed whole-exome sequencing and identified several novel mutated schwannoma genes. The specific roles of these mutations need further confirmation.

Keywords: mutation; schwannoma; surgical treatment; tracheal tumor; whole-exome sequencing.

Publication types

  • Case Reports